Can 'Microdosing' mindfulness ease long COVID's emotional toll?

NCT ID NCT05676008

Ongoing Symptom relief Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a short, online mindfulness program for people still suffering from long COVID symptoms like brain fog, fatigue, and pain. The program includes four training sessions and daily 'microdoses' of mindfulness activities. Researchers want to see if this approach can improve well-being and reduce stress, anxiety, and depression in 400 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: microdosing of mindfulness (behavioral intervention)
What this could lead to: If it works, this could offer a simple, drug-free way to help people with long COVID feel better emotionally and cope with ongoing symptoms.
What could go wrong: This is an early-stage behavioral study with no blinding or placebo control, so results may be influenced by participant expectations. The intervention is brief and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-ACUTE COVID-19 SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-ACUTE COVID-19 SYNDROME

Contacts and locations

Locations

University of California Davis

Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.